Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1390 participants.

Also called NCT02579889

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,390 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02579889
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China, Hungary, India, Italy, Malaysia, Singapore, South Korea, Spain, Taiwan (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02579889. Randomized; single masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2023-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease
Acronym
B3
Condition
Sinus Node Disease
Intervention (Device)
DDD+CLS
Intervention (Device)
DDD(R)
Lead sponsor
Biotronik SE & Co. KG (class: industry)

Record details

Record id
cardio:ct-nct02579889
Content hash
ea7b8dda2d2947be835bce1dd2d4f952b9ef0354d0c9e9008d181051a7375a4c